{"schema_version":"alpha-company-profile-public-v2","slug":"ars-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc","published_on":"2026-09-17T04:46:18.691255+00:00","last_reviewed_on":"2026-09-17T04:46:18.691255+00:00","identity":{"legal_name":"ARS Pharmaceuticals, Inc.","display_name":"ARS Pharmaceuticals, Inc.","headline":"ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology.","description":"ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001671858","logo":"https://cdn.brandfetch.io/ticker/spry/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/spry/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"ARS Pharmaceuticals, Inc. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-17T04:46:18.691255+00:00"},"security_listings":[{"ticker":"SPRY","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"ARS Pharmaceuticals, Inc.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"},{"label":"Sector","value":"Healthcare","source_id":"alpha-canonical-company-record"},{"label":"Industry","value":"Biotechnology","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/ars-pharmaceuticals-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-17T04:46:18.691255+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":21,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":2,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":21,"corroborated_claims":0,"sources":2,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-17T04:46:18.691255+00:00","observed_at":"2026-09-17T04:46:18.691255+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"ars-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc"},"publication":{"published_at":"2026-09-17T04:46:18.691255+00:00","last_reviewed_at":"2026-09-17T04:46:18.691255+00:00","as_of":"2026-09-17T04:46:18.691255+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"ars-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc","as_of":"2026-09-17T04:46:18.691255+00:00","last_reviewed_at":"2026-09-17T04:46:18.691255+00:00","identity":{"legal_name":"ARS Pharmaceuticals, Inc.","display_name":"ARS Pharmaceuticals, Inc.","description":"ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.","jurisdiction":null,"country":"US","sector":"Healthcare","industry":"Biotechnology","website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001671858","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"SPRY","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"72553d40-4a40-4a45-9726-dbfc6e08cc53","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-18","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"brenton-l-saunders-spry","display_name":"Brenton L. Saunders","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null},{"person_slug":"laura-shawver-spry","display_name":"Laura Shawver","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null},{"person_slug":"michael-kelly-spry","display_name":"Michael Kelly","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null},{"person_slug":"peter-a-thompson-spry","display_name":"Peter A Thompson","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null},{"person_slug":"peter-kolchinsky-spry","display_name":"Peter Kolchinsky","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null},{"person_slug":"phillip-schneider-spry","display_name":"Phillip Schneider","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null},{"person_slug":"pratik-shah-spry","display_name":"Pratik Shah","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null},{"person_slug":"rajeev-dadoo-spry","display_name":"Rajeev Dadoo","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null},{"person_slug":"saqib-islam-spry","display_name":"Saqib Islam","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.803855+00:00"},"headshot_url":null}],"executives":[{"person_slug":"alexander-a-fitzpatrick-spry","display_name":"Alexander A. Fitzpatrick","role_category":"executive","title":"Chief Legal Officer and Secretary","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.880907+00:00"},"headshot_url":null},{"person_slug":"brian-dorsey-spry","display_name":"Brian Dorsey","role_category":"executive","title":"Chief Operating Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.867045+00:00"},"headshot_url":null},{"person_slug":"eric-karas-spry","display_name":"Eric Karas","role_category":"executive","title":"Chief Commercial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.826601+00:00"},"headshot_url":null},{"person_slug":"justin-chakma-spry","display_name":"Justin Chakma","role_category":"executive","title":"Chief Business Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.835809+00:00"},"headshot_url":null},{"person_slug":"kathleen-d-scott-spry","display_name":"Kathleen D. Scott","role_category":"executive","title":"Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.814785+00:00"},"headshot_url":null},{"person_slug":"richard-lowenthal-spry","display_name":"Richard Lowenthal","role_category":"executive","title":"President and Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.845647+00:00"},"headshot_url":null},{"person_slug":"sarina-tanimoto-spry","display_name":"Sarina Tanimoto","role_category":"executive","title":"Chief Medical Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-29","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A spry-20260429.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm","source_type":"sec_proxy","published_at":"2026-04-29T00:00:00+00:00","effective_date":"2026-04-29","last_checked_at":"2026-09-02T02:50:13.853624+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc#profile","url":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc","dateModified":"2026-09-17T04:46:18.691255+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc#organization","legalName":"ARS Pharmaceuticals, Inc.","name":"ARS Pharmaceuticals, Inc.","description":"ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.","url":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Brenton L. Saunders","url":"https://registry.alpha.ac/people/brenton-l-saunders-spry"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-29","member":{"@type":"Person","name":"Laura Shawver","url":"https://registry.alpha.ac/people/laura-shawver-spry"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Michael Kelly","url":"https://registry.alpha.ac/people/michael-kelly-spry"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-29","member":{"@type":"Person","name":"Peter A Thompson","url":"https://registry.alpha.ac/people/peter-a-thompson-spry"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-29","member":{"@type":"Person","name":"Peter Kolchinsky","url":"https://registry.alpha.ac/people/peter-kolchinsky-spry"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Phillip Schneider","url":"https://registry.alpha.ac/people/phillip-schneider-spry"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-29","member":{"@type":"Person","name":"Pratik Shah","url":"https://registry.alpha.ac/people/pratik-shah-spry"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-29","member":{"@type":"Person","name":"Rajeev Dadoo","url":"https://registry.alpha.ac/people/rajeev-dadoo-spry"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-04-29","member":{"@type":"Person","name":"Saqib Islam","url":"https://registry.alpha.ac/people/saqib-islam-spry"}},{"@type":"OrganizationRole","roleName":"Chief Legal Officer and Secretary","startDate":"2026-04-29","member":{"@type":"Person","name":"Alexander A. Fitzpatrick","url":"https://registry.alpha.ac/people/alexander-a-fitzpatrick-spry"}},{"@type":"OrganizationRole","roleName":"Chief Operating Officer","startDate":"2026-04-29","member":{"@type":"Person","name":"Brian Dorsey","url":"https://registry.alpha.ac/people/brian-dorsey-spry"}},{"@type":"OrganizationRole","roleName":"Chief Commercial Officer","startDate":"2026-04-29","member":{"@type":"Person","name":"Eric Karas","url":"https://registry.alpha.ac/people/eric-karas-spry"}},{"@type":"OrganizationRole","roleName":"Chief Business Officer","startDate":"2026-04-29","member":{"@type":"Person","name":"Justin Chakma","url":"https://registry.alpha.ac/people/justin-chakma-spry"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer","startDate":"2026-04-29","member":{"@type":"Person","name":"Kathleen D. Scott","url":"https://registry.alpha.ac/people/kathleen-d-scott-spry"}},{"@type":"OrganizationRole","roleName":"President and Chief Executive Officer","startDate":"2026-04-29","member":{"@type":"Person","name":"Richard Lowenthal","url":"https://registry.alpha.ac/people/richard-lowenthal-spry"}},{"@type":"OrganizationRole","roleName":"Chief Medical Officer","startDate":"2026-04-29","member":{"@type":"Person","name":"Sarina Tanimoto","url":"https://registry.alpha.ac/people/sarina-tanimoto-spry"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/ars-pharmaceuticals-inc"},"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"}},"canonical_source":"aegis_canonical"}